Gainers
- Akero Therapeutics AKRO shares moved upwards by 117.9% to $57.05 during Monday's pre-market session. The company's market cap stands at $3.9 billion.
- Onconetix ONCO stock rose 48.52% to $0.71. The company's market cap stands at $5.9 million.
- 89bio ETNB stock moved upwards by 48.1% to $10.56. The company's market cap stands at $1.2 billion.
- Tevogen Bio Holdings TVGN stock increased by 37.03% to $1.85. The company's market cap stands at $323.8 million.
- Alumis ALMS shares rose 14.97% to $7.68. The company's market cap stands at $417.8 million.
- Healthcare Triangle HCTI stock rose 13.62% to $0.9. The market value of their outstanding shares is at $5.1 million.
Losers
- Allakos ALLK stock decreased by 76.0% to $0.29 during Monday's pre-market session. The market value of their outstanding shares is at $25.9 million.
- Aclarion ACON stock fell 23.5% to $0.04.
- Avenue Therapeutics ATXI shares fell 15.88% to $1.59. The company's market cap stands at $3.2 million.
- Unity Biotechnology UBX stock decreased by 15.13% to $2.02. The company's market cap stands at $34.0 million.
- Dogwood Therapeutics DWTX shares fell 13.95% to $9.81. The company's market cap stands at $13.0 million.
- CERo Therapeutics Hldgs CERO stock fell 11.24% to $2.2. The market value of their outstanding shares is at $6.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
ACONAclarion Inc
$10.81-0.09%
Edge Rankings
Momentum-
Growth11.24
Quality-
Value63.00
Price Trend
Short
Medium
Long
AKROAkero Therapeutics Inc
$36.44-0.79%
ALLKAllakos Inc
$0.3150-%
ALMSAlumis Inc
$9.66-3.88%
ATXIAvenue Therapeutics Inc
$0.2602-%
CEROCERo Therapeutics Holdings Inc
$0.6737-5.79%
DWTXDogwood Therapeutics Inc
$4.05-4.71%
ETNB89bio Inc
$5.780.17%
HCTIHealthcare Triangle Inc
$0.2234-0.27%
ONCOOnconetix Inc
$0.0718-0.28%
TVGNTevogen Bio Holdings Inc
$0.9727-3.69%
UBXUnity Biotechnology Inc
$0.92002.22%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in